Globus Medical (MEX:GMED) ROCE %: 13.28% (As of Mar. 2026)

What is Globus Medical ROCE %?

Globus Medical MEX:GMED 92 ROCE % is 13.28% as of Mar. 2026. GuruFocus rates MEX:GMED with a GF Score™ of 92/100 and a GF Value™ of MXN1,721.21 (Modestly Undervalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Globus Medical's annualized ROCE % for the quarter that ended in Mar. 2026 was 13.28%.

Globus Medical (MEX:GMED) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Globus Medical ROCE % Related Terms

Globus Medical ROCE % Historical Data

* Premium members only.

The historical data trend for Globus Medical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Globus Medical ROCE % Chart

Globus Medical Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

11.71

12.34

5.84

5.34

10.86

Globus Medical Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															8.91	10.64	11.63	15.23	13.28

92GF Score

Globus Medical Inc MEX:GMED

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Globus Medical ROCE % Calculation

Globus Medical's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	9672.5	/	( ( (109528.922 - 17850.665)	+	(95479.924 - 8975.823) )	/ 2 )
	=	9672.5	/	( (91678.257	+	86504.101)	/ 2 )
	=	9672.5	/	89091.179
	=	10.86 %

Globus Medical's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	11683.532	/	( ( (95479.924 - 8975.823)	+	(98089.864 - 8700.111) )	/ 2 )
	=	11683.532	/	( ( 86504.101	+	89389.753 )	/ 2 )
	=	11683.532	/	87946.927
	=	13.28 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 13.28% mean?

Globus Medical (MEX:GMED) has a ROCE % of 13.28% as of Mar. 2026.

Is Globus Medical's ROCE % too high?

Globus Medical's current ROCE % is 13.28%. The Medical Devices & Instruments industry median ROCE % is 2.20. Globus Medical's value of 13.28% is 503.6% above this industry median. Overall, Globus Medical has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Globus Medical's ROCE % compare to PEN and PODD?

Globus Medical's ROCE % of 13.28% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.20. Globus Medical's value of 13.28% is 503.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Devices & Instruments company?

The median ROCE % among Medical Devices & Instruments companies is 2.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Globus Medical's current ROCE % of 13.28% is 503.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Globus Medical's current ROCE % is 13.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Globus Medical stock overvalued right now?

Based on GuruFocus' analysis, Globus Medical (MEX:GMED) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,721.21, compared to a current price of MXN1,465.00 — trading 14.9% below its estimated fair value. The current ROCE % is 13.28% and 503.6% above the Medical Devices & Instruments industry median of 2.20. Globus Medical's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Globus Medical (MEX:GMED), the current ROCE % is 13.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Globus Medical (MEX:GMED) Overvalued in 2026?

Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued. The current stock price of MXN1,465.00 is trading 14.9% below its estimated GF Value™ of MXN1,721.21. GuruFocus considers Globus Medical to be Modestly Undervalued.

Key valuation signals for MEX:GMED:

ROCE %: 13.28%
GF Value™: MXN1,721.21 vs. price of MXN1,465.00 (14.9% below fair value)
GF Score™: 92/100 with 4 warning signs
Industry Position: 503.6% above the Medical Devices & Instruments median

No single metric tells the full story. See the MEX:GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Globus Medical Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies PEN PODD BRKR GKOS BIO ZBH LIVN IRTC HAE ITGR ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Other Exchanges GMED:USA GM0N:Germany

Address 2560 General Armistead Avenue, Audubon, PA, USA, 19403

Website https://www.globusmedical.com

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

92GF Score

Get the complete analysis for MEX:GMED

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,465.00

Price

MXN1,721.21

GF Value

View MEX:GMED Analysis

See ROCE % data for all stocks →